Sevelamer Hydrochloride Tablet, Film Coated
Product Images NDC 59651-088

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 59651-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Sevelamer Fig1)

Figure 1 (Sevelamer Fig1)
FDA Label Image

Figure 2 (Sevelamer Fig2)

Figure 2 (Sevelamer Fig2)
FDA Label Image

Package Label.principal Display Panel- 400 mg (360 Tablets Bottle) (Sevelamer Fig3)

Package Label.principal Display Panel- 400 mg (360 Tablets Bottle) (Sevelamer Fig3)
FDA Label Image

Fig4 (Sevelamer Fig4)

Fig4 (Sevelamer Fig4)
Distributed by Aurobindo Pharma USA, Inc., this film-coated tablet contains Sevelamer hydrochloride 800 mg as its active ingredient. The tablet also includes several inactive ingredients such as black iron oxide, colloidal silicon dioxide, glyceryl dibehenate, and hydroxypropyl cellulose. It is recommended to store the tablet in a tight container at a temperature of 20°C to 25°C (68°F to 77°F).*
FDA Label Image

Chemical Structure (Sevelamer Str)

Chemical Structure (Sevelamer Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.